Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1961 1
1962 2
1963 2
1964 3
1965 2
1968 5
1969 6
1970 5
1971 3
1972 6
1973 4
1974 8
1975 3
1976 7
1977 11
1978 11
1979 7
1980 6
1981 6
1982 9
1983 15
1984 9
1985 18
1986 16
1987 19
1988 18
1989 28
1990 36
1991 36
1992 38
1993 27
1994 32
1995 39
1996 44
1997 52
1998 83
1999 75
2000 87
2001 94
2002 108
2003 125
2004 145
2005 177
2006 191
2007 201
2008 280
2009 314
2010 398
2011 399
2012 474
2013 532
2014 652
2015 699
2016 708
2017 795
2018 907
2019 1010
2020 1048
2021 1173
2022 1314
2023 1293
2024 422

Text availability

Article attribute

Article type

Publication date

Search Results

12,801 results

Results by year

Filters applied: . Clear all
Page 1
Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization.
Ye T, Jiao Z, Li X, He Z, Li Y, Yang F, Zhao X, Wang Y, Huang W, Qin M, Feng Y, Qiu Y, Yang W, Hu L, Hu Y, Zhai Y, Wang E, Yu D, Wang S, Yue H, Wang Y, Wang H, Zhu L, Ma G, Wei W. Ye T, et al. Among authors: yu d. Nature. 2023 Dec;624(7992):630-638. doi: 10.1038/s41586-023-06809-8. Epub 2023 Dec 13. Nature. 2023. PMID: 38093012
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer: The Neotorch Randomized Clinical Trial.
Lu S, Zhang W, Wu L, Wang W, Zhang P; Neotorch Investigators; Fang W, Xing W, Chen Q, Yang L, Mei J, Tan L, Sun X, Xu S, Hu X, Yu G, Yu D, Yang N, Chen Y, Shan J, Xing L, Tian H, Zhang X, Zhou M, Fang H, Wu G, Liu Y, Ye M, Cao L, Jiang J, Li X, Zhu L, Li D, Kang M, Zhong A, Chen K, Wu N, Sun Q, Ma H, Cai K, Wang C, Lin G, Zhu K, Zhang Y, Zhang X, Hu H, Zhang W, Chen J, Yang Z, Hang X, Hu J, Huang Y, Zhang Z, Zhang L, Zhang L, Liu L, Lin D, Zhang J, Chen G, Li Y, Zhu L, Wang W, Yu W, Cao D, Keegan P, Yao S. Lu S, et al. Among authors: yu d. JAMA. 2024 Jan 16;331(3):201-211. doi: 10.1001/jama.2023.24735. JAMA. 2024. PMID: 38227033 Clinical Trial.
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency.
Le Voyer T, Parent AV, Liu X, Cederholm A, Gervais A, Rosain J, Nguyen T, Perez Lorenzo M, Rackaityte E, Rinchai D, Zhang P, Bizien L, Hancioglu G, Ghillani-Dalbin P, Charuel JL, Philippot Q, Gueye MS, Maglorius Renkilaraj MRL, Ogishi M, Soudée C, Migaud M, Rozenberg F, Momenilandi M, Riller Q, Imberti L, Delmonte OM, Müller G, Keller B, Orrego J, Franco Gallego WA, Rubin T, Emiroglu M, Parvaneh N, Eriksson D, Aranda-Guillen M, Berrios DI, Vong L, Katelaris CH, Mustillo P, Raedler J, Bohlen J, Bengi Celik J, Astudillo C, Winter S; NF-κB Consortium; COVID Human Genetic Effort; McLean C, Guffroy A, DeRisi JL, Yu D, Miller C, Feng Y, Guichard A, Béziat V, Bustamante J, Pan-Hammarström Q, Zhang Y, Rosen LB, Holland SM, Bosticardo M, Kenney H, Castagnoli R, Slade CA, Boztuğ K, Mahlaoui N, Latour S, Abraham RS, Lougaris V, Hauck F, Sediva A, Atschekzei F, Sogkas G, Poli MC, Slatter MA, Palterer B, Keller MD, Pinzon-Charry A, Sullivan A, Droney L, Suan D, Wong M, Kane A, Hu H, Ma C, Grombiříková H, Ciznar P, Dalal I, Aladjidi N, Hie M, Lazaro E, Franco J, Keles S, Malphettes M, Pasquet M, Maccari ME, Meinhardt A, Ikinciogullari A, Shahrooei M, Celmeli F, Frosk P, Goodnow CC, Gray … See abstract for full author list ➔ Le Voyer T, et al. Among authors: yu d. Nature. 2023 Nov;623(7988):803-813. doi: 10.1038/s41586-023-06717-x. Epub 2023 Nov 8. Nature. 2023. PMID: 37938781 Free PMC article.
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.
Tricou V, Yu D, Reynales H, Biswal S, Saez-Llorens X, Sirivichayakul C, Lopez P, Borja-Tabora C, Bravo L, Kosalaraksa P, Vargas LM, Alera MT, Rivera L, Watanaveeradej V, Dietze R, Fernando L, Wickramasinghe VP, Moreira ED Jr, Fernando AD, Gunasekera D, Luz K, Oliveira AL, Tuboi S, Escudero I, Hutagalung Y, Lloyd E, Rauscher M, Zent O, Folschweiller N, LeFevre I, Espinoza F, Wallace D. Tricou V, et al. Among authors: yu d. Lancet Glob Health. 2024 Feb;12(2):e257-e270. doi: 10.1016/S2214-109X(23)00522-3. Lancet Glob Health. 2024. PMID: 38245116 Free article. Clinical Trial.
Research Advances in Superabsorbent Polymers.
Yang Y, Liang Z, Zhang R, Zhou S, Yang H, Chen Y, Zhang J, Yin H, Yu D. Yang Y, et al. Among authors: yu d. Polymers (Basel). 2024 Feb 12;16(4):501. doi: 10.3390/polym16040501. Polymers (Basel). 2024. PMID: 38399879 Free PMC article. Review.
Engineering and Targeting Neutrophils for Cancer Therapy.
Zhang J, Gu J, Wang X, Ji C, Yu D, Wang M, Pan J, Santos HA, Zhang H, Zhang X. Zhang J, et al. Among authors: yu d. Adv Mater. 2024 Feb 6:e2310318. doi: 10.1002/adma.202310318. Online ahead of print. Adv Mater. 2024. PMID: 38320755 Review.
Dimensionality reduction under scrutiny.
Yang Y, Tuong ZK, Yu D. Yang Y, et al. Among authors: yu d. Nat Comput Sci. 2023 Jan;3(1):8-9. doi: 10.1038/s43588-022-00383-1. Nat Comput Sci. 2023. PMID: 38177957 No abstract available.
Raman encoding for security labels: a review.
Yu D, Zhu W, Shen AG. Yu D, et al. Nanoscale Adv. 2023 Oct 18;5(23):6365-6381. doi: 10.1039/d3na00707c. eCollection 2023 Nov 21. Nanoscale Adv. 2023. PMID: 38024325 Free PMC article. Review.
12,801 results
You have reached the last available page of results. Please see the User Guide for more information.